ArticleFrontiers in immunology2025

The efficacy, safety, and pharmacokinetics/pharmacodynamics of telitacicept following efgartigimod in generalized myasthenia gravis: protocol of a randomized controlled trial.

Jia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.